Background-Depression is prevalent among patients with myocardial infarction and is associated with a worse prognosis.
D epression is prevalent among patients with coronary artery disease and has significant consequences. After myocardial infarction (MI), the incidence of depression has been estimated to range between 10% and 40%, [1] [2] [3] and similar rates have been reported after coronary artery bypass graft (CABG). [4] [5] [6] Studies that have examined the impact of depression in patients who have experienced an MI have consistently found that it is associated with adverse outcomes. Patients with post-MI depression have a 1.6-to 2.7-fold increased risk of new cardiac events, cardiac mortality, and all-cause mortality within 24 months. 7 They also have an increased rate of subsequent heart failure, 8 hospital readmissions, 9 and overall increased healthcare resource utilization. 9 There have been several biological mechanisms by which depression may be related to coronary artery disease. As compared with nondepressed patients, those with depression have increased catecholamine levels, 10 elevated resting heart rate, 11 and decreased heart rate variability, 12 all of which suggest increased sympathetic activity. Behavioral characteristics of patients with depression include poor medication adherence, 13 lower exercise tolerance, 14 physical inactivity, 15 poor dietary habits, 16 and tobacco use. 17 Although depression and its impact have been well documented in post-MI patients, much less is known about its significance in patients with chronic stable angina. [18] [19] [20] Despite the fact that stable angina is the most common manifestation of coronary artery disease, 21, 22 studies to date on the relationship between depression and chronic stable angina in the ambulatory setting have been small or restricted to a single center. 15, [23] [24] [25] Further insight into the prognostic importance of services. It captures information such as diagnostic codes and dates of service. Mortality was ascertained through the Registered Persons Database. CIHI-DAD contains data from hospital admissions and discharges, and the National Ambulatory Care Reporting System collects data from emergency department visits. Physician specialization was obtained from the ICES Physician Database. The Ontario Mental Health Reporting System reports on individuals admitted to adult mental health beds in Ontario. Hospitals disclose information to the Ontario Mental Health Reporting System, such as diagnostic codes, when a patient is admitted, discharged, or experiences a significant change in their mental health status. The Ontario Drug Benefit program provides full drug coverage for patients over the age of 65 and also contains accurate drug utilization information.
Patient Selection
Our cohort included residents over the age of 20 years with a valid health card number who had newly diagnosed stable angina, based on obstructive coronary artery disease found on an index coronary angiogram. Accrual began on October 1, 2008, and ended on September 30, 2013. The maximum follow-up date was September 30, 2014, for a minimum of 1-year follow-up on all patients. We included only the first angiogram in patients who underwent multiple angiograms within this time period. Obstructive disease was defined as >70% luminal stenosis in one or more major epicardial vessels or >50% luminal stenosis in the left main coronary artery. We excluded patients who presented with acute coronary syndrome and those with a previous history of coronary artery disease based on a previous MI, acute coronary syndrome, percutaneous coronary intervention, or CABG. We also excluded patients with a recent history of depression defined by documentation of depression in the 3-year look back window starting April 1, 2005, based on the same diagnostic codes as described later.
Depression
We defined depression based on any combination of diagnostic codes obtained from physician claims codes (OHIP) and in-hospital/emergency department visits. The diagnostic codes in OHIP that were used to define depression included reactive depression (300) and depression (311). Depression was identified from CIHI-DAD and the National Ambulatory Care Reporting System using International Classification of Diseases, 10th Revision diagnostic codes for depression in any of the most responsible or comorbidities fields (see Table  I in the Data Supplement). Although not formally validated by chart review, these codes have been used in other studies using administrative data to examine depression. [29] [30] [31] Codes associated with bipolar disorder in the CIHI-DAD, National Ambulatory Care Reporting System, or OHIP databases were excluded. In the Ontario Mental Health Reporting System, depression was defined using Diagnostic and Statistical Manual of Mental Disorders, 4th Edition codes as a single (296.20-0.26) or recurrent (296.30-0.36) episode of major depressive disorder as determined by a psychiatrist or attending physician during admission to an inpatient mental health bed. If a patient had any of these codes in the observation period from their first angiogram (October 1, 2008, to September 30, 2013) until the maximum follow-up date of September 30, 2014, they were classified as having depression. Among these patients, we determined time from index catheterization to the first episode of depression during the follow-up period and also the speciality of the physician (family physician versus psychiatrist) who diagnosed the depressive episode. In addition, we determined the proportion of patients over the age of 65 years on pharmacotherapy within 6 months of their first depressive episode (see Table II in the Data Supplement). Given the possible relationship between a remote diagnosis of depression and reoccurrence post angiography, we determined the proportion of patients with a diagnosis of depression 10 years before the index angiogram and included this as a predictor in our statistical models.
Outcomes
The primary outcome was all-cause mortality ascertained through the Registered Persons Database. Secondary outcomes included admission
WHAT IS KNOWN
• Depression is common in patients after myocardial infarction and associated with poor outcomes, but its relationship with stable angina is less well established.
WHAT THE STUDY ADDS
• Occurrence of depression after a new diagnosis of stable angina is common and affects nearly 1 in 5 individuals. • The strongest predictor of depression post angiography is a remote history of depression. • Occurrence of depression is associated with poor outcomes, including death and myocardial infarction.
for MI based on the CIHI-DAD using most responsible International Classification of Diseases, 10th Revision diagnostic codes based on a validated algorithm. 32 In addition, we determined subsequent revascularization (percutaneous coronary intervention or CABG) based on the CCN Cardiac registry, supplemented by data in the CIHI-DAD.
Statistical Analysis
To compare baseline characteristics of patients who developed depression to those who did not, t test was used for continuous variables, and χ 2 tests were used for categorical variables.
Objective 1
To determine patient-, physician-, and hospital-level predictors of receiving a diagnosis of depression, multivariable Cox proportional hazards regression models were developed. We used a robust sandwich variance estimator to account for any possible clustering of patients by hospital where index coronary angiogram was performed.
Objective 2
Kaplan-Meier curves were developed for unadjusted outcomes and compared using a log-rank test. Fully adjusted Cox proportional models were developed in our full cohort to examine the relationship between the occurrence of depression after angiogram and clinical outcomes. In these models, depression was treated as a time-varying variable. This type of analysis controls for potential immortal time bias. 33 Robust sandwich-type variance estimators accounted for potential homogeneity in outcomes for clusters of patients treated at the same hospital. These models were fully adjusted for patient-, physician-, and hospital-level variables. As a sensitivity analysis, we restricted the analysis to only patients who were diagnosed with an occurrence of depression post angiography. We then examined the impact of the timing of diagnosis of depression after angiogram on all-cause mortality, MI, and revascularization by comparing the outcomes for depression in patients who experienced an occurrence within 30 days of the angiogram to those who experienced an occurrence at later intervals. All data analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, NC). Statistical significance was considered to be 2-sided P values of <0.05.
Results

Patients
Between October 1, 2008, and September 30, 2013, 272 250 angiograms were performed in patients who were referred for investigation of possible coronary artery disease. As seen in Figure, our final cohort consisted of 22 917 patients with stable angina based on obstructive coronary artery disease on an index angiogram. Approximately 12.7% of patients were excluded because of a recent diagnosis of depression; however, 31.1% in the final cohort had a remote diagnosis of depression within the previous 10 years. In our cohort, 4305 (18.8%) patients were found to have experienced their first occurrence of depression after angiogram over a mean follow-up of 1084 days (rate of 63.2/1000 patient years). Of the patients with depression, 84.9% were identified by family physicians, whereas 8.1% were identified by psychiatrists. With respect to timing of the depressive episode, 343 (8.0%) patients were recognized as depressed within 30 days, 445 (10.3%) at 30 to 90 days, 447 (10.4%) at 90 to 180 days, 726 (16.9%) at 180 to 365 days, with the remainder (54.4%) experiencing a depressive episode beyond 1 year after their index angiogram. Of the patients with depression over the age of 65 years, 36% were on antidepressant pharmacotherapy.
The baseline characteristics of the cohort are listed in Table 1 . There were several differences between patients with and without depression, including a higher percentage of males and residents of rural areas among patients without depression. In addition, there were more smokers among the patients with depression, as well as a higher prevalence of peripheral vascular disease, and the traditional risk factors of diabetes mellitus, hypertension, and hyperlipidemia. In terms of initial treatment strategy, more patients who underwent CABG subsequently experienced depression; however, these differences were modest ( Table 1 ).
Predictors of Depression
Independent predictors of developing depression are found in 
Clinical Outcomes
Unadjusted all-cause mortality was higher in patients with depression than in those without depression (7.6% and 6.4%, respectively; P=0.005). Similar findings were found for other unadjusted clinical outcomes, including admission for MI (4.7% and 2.8%, respectively; P<0.001) and subsequent revascularization (14.0% and 10.7% respectively; P<0.001).
As seen in Table 3 , in the fully adjusted model, depression was associated with an 83% increased hazard of death (HR 1.83, 95% CI 1.62-2.07; P<0.001). Depression was also significantly associated with admission for MI (HR 1.36, 95% CI 1.10-1.67; P=0.005). There was no significant effect of depression on the need for subsequent revascularization (HR 1.13, 95% CI 0.99-1.28; P=0.07; see Table III in the Data Supplement for full multivariable Cox models). In the sensitivity analysis restricted to patients with depression, time to first episode of depression was not an important predictor of clinical outcomes (Table IV in the Data Supplement) . When compared with patients who experienced depression within 30 days of their angiogram, those who had an occurrence in later periods did not have statistically significant differences in subsequent outcomes.
Discussion
In this retrospective population-based cohort study, the occurrence of depression after diagnosis of chronic stable angina was 18.8% or roughly 1 in 5 patients. We found that patients with chronic stable angina who experienced a depressive episode had a worse prognosis, with a significantly higher likelihood of all-cause mortality and admission for MI.
Our findings complement the current literature on depression and cardiovascular disease, which has thus far focused on more acute manifestations of coronary artery disease, in contrast to stable angina. Similar to the post-MI population, however, we found that patients with chronic stable angina are at a high risk of experiencing depression. Our study is unique in that it evaluated angina patients at a population level using a contemporary province-wide registry. As such, it adds to the literature by providing useful insights into the occurrence of depression in the outpatient and ambulatory care setting and indicates patients with coronary artery disease are susceptible to depression irrespective of whether they have experienced a major cardiac event requiring hospitalization.
In this study, predictors of depression in the setting of chronic stable angina were consistent with the current literature on depression. In particular, it is important to recognize the importance of a previous, remote history of depression, which was the strongest predictor of a subsequent occurrence, reinforcing the remitting and relapsing nature of depression.
In general, women are more likely to suffer depression than men, 3 and we found this to be true for patients with stable chronic angina. Various plausible biological and environmental mechanisms have been studied, including the role of sex hormones and women's social roles, to explain this sex disparity, but to date none have been conclusive. 34 Our results also showed that a higher Charlson score and smoking were associated with depression. These findings are in keeping with previous work that has shown individuals with multiple comorbid medical illnesses are vulnerable to mood disorders. 17 CCS class 4 angina symptoms were also an important predictor of depression in our cohort, potentially because of increased symptom burden, leading to physical limitations, decreased quality of life, and, hence, depression. 35 There was no significant relationship between initial treatment strategy and depression, which suggests that revascularization does not mitigate future risk of a depressive episode.
We found that depression was an important predictor for adverse outcomes in stable angina, and this has been similarly observed in post-MI and CABG patients. A recent metaanalysis by Meijer et al 7 reported an increased likelihood of all-cause mortality and cardiac events among post-MI patients who developed depression. Connerney et al 4 found that patients who underwent CABG and met Diagnostic and Statistical Manual of Mental Disorders, 4th Edition criteria for major depression had a 2-fold increased risk of death or readmission for cardiac causes within 12 months. Similar to post-MI and CABG patients, the higher likelihood of death and readmission for MI associated with depression in patients with chronic stable angina is likely multifactorial in pathogenesis, involving both biological mechanisms and health behaviors, such as medication noncompliance. In our cohort, this may have been reflected in the fact that patients who developed depression had a slightly more unfavorable cardiovascular risk factor profile.
Our findings indicate that patients may experience their first depressive episode at any given time after diagnosis of chronic stable angina; it may occur shortly after an individual is found to have obstructive coronary artery disease or several years after this diagnosis. Unfortunately, depression is often recurrent in patients with coronary artery disease 24 and, without treatment, is likely to persist. Studies have shown that cognitive behavioral therapy may reduce depressive symptoms, 36 and antidepressants may improve cardiac outcomes, as suggested by a post hoc analysis of the Enhancing Recovery in Coronary Heart Disease Patients trial. 37 The possible benefits of treating depression provide an opportunity to reduce adverse cardiovascular outcomes and their associated costs in this population. 
Limitations
Our results should be interpreted in the context of the following limitations that merit discussion. The majority of previous work done in the area of depression and coronary artery disease defined depression based on structured psychiatric interviews or screening instruments, such as the Patient Health Questionnaire. We defined depression more broadly with International Classification of Diseases, 10th Revision diagnostic codes validated for depressive disorders, as well as with OHIP diagnostic codes used by primary care providers for presentations related to mood disturbances. As a result, patients with depression outside the formal Diagnostic and Statistical Manual of Mental Disorders, 4th Edition criteria for major depressive disorder were included in the cohort, and this likely included some patients with general psychosocial distress. The fact that only one third of patients were on pharmacotherapy reinforces this point. This may have resulted in a misclassification bias and, consequently, in an inflation of the occurrence of depression as well as a dilution of the association with outcomes. However, with this inclusive definition, the presence of depression as we defined it was, nonetheless, significantly predictive of all-cause mortality and admission for MI. This is important to emphasize because it suggests that a formal diagnosis of major depressive disorder is not required for an impact on outcomes and that patients with true major depressive disorder based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition criteria may have an even worse prognosis than estimated by our results. Second, to control for immortal time bias, depression was treated as a time-varying covariate in Cox proportional hazards models. Residual survivorship would tend to bias to the null, in that patients who died early would be classified in the no depression category. As such, we may be underestimating the impact of depression on clinical outcomes. It is important to acknowledge that directionality of the relationship between angina and depression cannot be confirmed from our analysis. It is possible that patients with escalating angina symptoms have greater clinical follow-up and, therefore, more opportunity for a diagnosis of depression as opposed to vice versa. In addition, we were only able to evaluate all-cause mortality, as cause-specific mortality was not available in the administrative databases used in our study. Furthermore, we only included patients with a diagnosis of stable angina based on an angiogram; this represents a more restrictive subset of patients with stable angina, many of whom would be diagnosed based on noninvasive testing. Caution should be applied in generalizing our results to this broader population. This cohort study showed that patients with chronic stable angina diagnosed at the time of angiography are at a high risk for experiencing depression. Similar to post-MI patients, the presence of depression portends a worse prognosis independent of traditional cardiac risk factors. Our findings suggest depression may relapse or develop at any point in time after a diagnosis of stable angina. Co-morbid depression and chronic stable angina have significant clinical implications, and further attention to finding efficacious treatments is warranted.
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